T B V

Tiens Biotech Group USA Inc., Ticker (TBV), operates primarily through its China-based subsidiary Tiens Biological Development CO. Ltd. Tiens Biological has developed and produced seven major product series, of which six comprise nutrition supplement products, and the seventh comprises personal care products. It develops its products at its own product research and development center and conducts the marketing and sales of its products through its affiliated company, which owns 23 branches, representative offices and chain stores.
Tiens Biotech Group Inc. is an AMEX listed security that has been trading in a range between $2.61 and $6.99 over the past year. With 71,333,590 shares outstanding, a recent price of $4.04 gives a total market capitalization of $285,334,360. While there are certainly larger companies, Tiens Biotech Group Inc. has definitely earned its place in the pack. Last year, Tiens Biotech Group Inc. created $0.37 in earnings for every share outstanding.
With a share price under $50 a share and earnings per share below $1 a share, Tiens Biotech Group Inc. could be an interesting value proposition